Home Department: Bioengineering
Supported by: Bio-X
Mentor: Paul Wang, Medicine (Cardiovascular)

Catheter ablation is an invasive procedure that has been the gold standard for treating atrial fibrillation (AF), a heart disease that affects more than two million patients in the U.S.; however, the success rate among patients with enlarged atria is less than 30% due to incomplete lesions that do not span the entire thickness of the heart tissue. To tackle this, Andrew is designing and testing a magnetic monorail ablation device that will benefit many patients who suffer from persistent AF and cannot undergo traditional catheter ablation therapy.

Poster presented at the Stanford Bio-X Interdisciplinary Initiatives Symposium on August 24, 2016:

Developing a Novel Bipolar Catheter Ablation System for Treating Ventricular Tachycardia

Andrew Lee¹, Meghedi Babakhanian², Paul J. Wang^1,2
[Departments of Bioengineering¹ and Cardiovascular Medicine², Stanford University]